3rd Annual Advances in Immuno-Oncology Congress
3rd Annual Advances in Immuno-Oncology Congress
24-25 May 2018, London, UK
View the Agenda here: http://bit.ly/2oJlVB7
Oxford Global is proud to present the 3rd Annual Advances in Immuno-Oncology Congress taking place on 24–25 May 2018 in London, UK, featuring over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate. Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.
6 interactive streams:
- Discovery of Immuno-Oncology Therapies
- Translational Immuno-Oncology
- Genomics in Cancer Immunotherapy and Precision Medicine
- Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
- Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials
- Microbiome in Immuno-Oncology
Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
MabDesign Pharma/Biotech members benefit of 20% discount on registration. Ask us for the code !
Free Pre-Congress Live Webinars
Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment
Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd
Register today, for free: http://bit.ly/2mGZNmO
Personalised Medicine and Immuno-Oncology
Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody
Register today, for free: http://bit.ly/2rigNFh
Can’t make the dates? Still register and a copy of the webinar recording can be sent to you.
Register
